NCT00887562View on ClinicalTrials.gov

Study of Idebenone in the Treatment of Mitochondrial Encephalopathy Lactic Acidosis & Stroke-like Episodes

PHASE2CompletedINTERVENTIONAL

Enrollment

27

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

MELAS Syndrome

Interventions

DRUG

Idebenone

900 mg/day for 1 month

DRUG

Idebenone

2250 mg/day for 1 month

OTHER

Placebo

Placebo - No idebenone

Trial Locations (1)

10032

Columbia University Medical Center, New York

Sponsors

Collaborators (1)

Santhera Pharmaceuticals

All Listed Sponsors

collaborator

Santhera Pharmaceuticals

INDUSTRY

lead

Michio Hirano

OTHER

NCT00887562 - Study of Idebenone in the Treatment of Mitochondrial Encephalopathy Lactic Acidosis & Stroke-like Episodes | Biotech Hunter | Biotech Hunter